Table 2 |
|||
|
Clinical classification based on GINA guidelines of all asthmatics, including those who returned a positive challenge |
|||
| ADULTS |
Mild |
Moderate |
Severe |
|
|
|||
| n (Total) |
191 |
151 |
36 |
| n (with PD15) |
80 |
107 |
35 |
| GeoMean PD15 mg (95% CI) |
186 (148, 233) |
78* (58, 106) |
56* (36, 98) |
|
|
|||
| CHILDREN |
Infrequent Episodic |
Frequent Episodic |
Persistent |
|
|
|||
| n (Total) |
24 |
19 |
66 |
| n (with PD15) |
18 |
14 |
54 |
| GeoMean PD15 mg (95% CI) |
113 (59, 217) |
117 (73, 187) |
67 (46, 99) |
|
* p < 0.001 compared with mild | |||
Brannan et al. Respiratory Research 2005 6:144 doi:10.1186/1465-9921-6-144 |
|||
